poisar

Stocks · News reference

Altria Files Lawsuit Against The U.S. FDA In Texas; Altria Lawsuit Against The U.S. FDA Seeks To Force The FDA To Scrap Its System For Reviewing New Tobacco Products Before They Can Market

Benzinga Newsdesk
More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

MO
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Leo Sun

    2 Dividend Kings to Buy Now and 1 to Avoid Despite the Yield

    Among three Dividend Kings—Coca-Cola, PepsiCo, and Altria—analyst recommends buying Coca-Cola and Altria while avoiding PepsiCo. Coca-Cola's asset-light model and diversification provide reliable income, while Altria's expansion into smoke-free products offers growth potential. PepsiCo's asset-heavy beverage business and struggling packaged foods segment face more significant near-term challenges despite attractive valuation.

    KOMOPEP
  4. Lawrence Rothman, Cfa

    If You Invest $150 Per Month in Altria Group Stock, Here's the Passive Dividend Income It Could Generate Over 10 Years

    Altria Group, a Dividend King with 61 consecutive dividend increases over 57 years, could generate between $7,430 and $10,160 in dividend income over 10 years with $150 monthly investments, depending on dividend growth rates of 2-6% annually. The analysis assumes dividend reinvestment and a flat share price, with actual after-tax returns varying based on individual tax situations.

    MO